Erratum: Candesartan induces tumor vascular normalization to improve the efficacy of radiotherapy in the therapeutic window
Erratum to: Ann Transl Med 2022;10:581.
The article (1) titled “Candesartan induces tumor vascular normalization to improve the efficacy of radiotherapy in the therapeutic window” (doi: 10.21037/atm-22-2108) unfortunately contains an error in Figure 6. The representative images of tumor stained with Figure 6B Control group were incorrect.
Figure 6 of the original article:
Correct Figure 6:
The authors sincerely apologize for any confusion these errors may have caused, and confirm these corrections do not significantly impact the overall findings and conclusions of the paper.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Zhu F, Yao W, Huang Y, et al. Candesartan induces tumor vascular normalization to improve the efficacy of radiotherapy in the therapeutic window. Ann Transl Med 2022;10:581. [Crossref] [PubMed]
